Also, a study by Waschbisch et al., 2014 provided evidence that IFN‐mediated induction of ILT3 can be potentiated by vitamin D. Results of study by Rinaldi et al., 2015 confirmed that MS patients have higher vitamin D‐binding protein (DBP) levels than healthy subjects. This evidence concerns the gene LILRB4 and myeloid sarcoma.